Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21 Clinical Trial Optional)

Funder: The National Institutes of Health

Due Date: July 30, 2018

Budget: Negotiable

Opportunity: PAR-18-245

The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, collaborative research projects in the NCATS’ Clinical and Translational Science Award (CTSA) program, with the goal of assessing utility and feasibility of proposed innovation(s).

Leave a Reply